Are you living with moderately to severely active Ulcerative Colitis (UC) and have previous treatments not worked well enough for you? You may be eligible to participate in a Phase II/III clinical research study evaluating a novel oral treatment with a new mechanism of action.

This study is evaluating the safety and effectiveness of the investigational study drug in people with moderately to severely active UC who have had an inadequate response to or failed previous conventional or advanced UC therapies.

If you are interested in participating and would like to learn more about eligibility and what the study involves, contact our research team today.